Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain
Biochem Soc Trans. 2018 Apr 17;46(2):207-215. doi: 10.1042/BST20170130. Epub 2018 Feb 22.
Lysosomes are acidic organelles that contain hydrolytic enzymes that mediate the intracellular degradation of macromolecules. Damage of these organelles often results in lysosomal membrane permeabilization (LMP) and the release into the cytoplasm of the soluble lysosomal contents, which include proteolytic enzymes of the cathepsin family. This, in turn, activates several intracellular cascades that promote a type of regulated cell death, called lysosome-dependent cell death (LDCD). LDCD can be inhibited by pharmacological or genetic blockade of cathepsin activity, or by protecting the lysosomal membrane, thereby stabilizing the organelle. Lysosomal alterations are common in cancer cells and may increase the sensitivity of these cells to agents that promote LMP. In this review, we summarize recent findings supporting the use of LDCD as a means of killing cancer cells.
溶酶体是酸性细胞器,其中含有水解酶,可介导细胞内大分子的降解。这些细胞器的损伤通常会导致溶酶体膜通透性增加(LMP),并将可溶性溶酶体内容物释放到细胞质中,其中包括组织蛋白酶家族的蛋白水解酶。这反过来又激活了几个细胞内级联反应,促进了一种称为溶酶体依赖性细胞死亡(LDCD)的细胞死亡。LDCD 可以通过药理学或遗传阻断组织蛋白酶活性来抑制,或者通过保护溶酶体膜来稳定细胞器。溶酶体改变在癌细胞中很常见,并且可能增加这些细胞对促进 LMP 的药物的敏感性。在这篇综述中,我们总结了支持将 LDCD 用作杀死癌细胞的手段的最新发现。